Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Change in Inventory (2013 - 2026)

Exelixis (EXEL) posted quarterly Change in Inventory of $3.4 million for Q2 2026, up 4673.24% year-over-year from $71000.0 in Q2 2025, and up 124.55% quarter-over-quarter from -$13.8 million in Q1 2026.

Analysis

Exelixis (EXEL) Change in Inventory (2013 - 2026) Analysis & Trends

Exelixis' Change in Inventory history runs 14 years deep, the most recent figure standing at $3.4 million for Q2 2026.

  • In Q2 2026, Change in Inventory rose 4673.24% year-over-year to $3.4 million; the TTM figure through Apr 2026 stood at -$8.9 million (down 142.9% YoY), while the FY2026 annual figure was -$12.2 million, down 124.19% from the prior year.
  • Change in Inventory for Q2 2026 stood at $3.4 million, up from -$13.8 million in the prior quarter.
  • The five-year high for Change in Inventory was $8.4 million in Q1 2023, with the low at -$13.8 million in Q1 2026.
  • The 5-year median for Change in Inventory is $1.5 million (2022), against an average of $610058.8.
  • Peak annual rise in Change in Inventory reached 4673.24% in 2026, while the deepest fall reached 399.86% in 2026.
  • Exelixis' Change in Inventory stood at $1.8 million in 2022, then slumped by 182.62% to -$1.5 million in 2023, then soared by 125.16% to $384000.0 in 2024, then surged by 980.47% to $4.1 million in 2025, then dropped by 18.32% to $3.4 million in 2026.
  • Business Quant data shows EXEL's Change in Inventory at $3.4 million in Q2 2026, -$13.8 million in Q1 2026, and $4.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 27.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 28.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 132.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 47.15 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -280,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 12.97 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 44,000.00
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 44,000.00
Apr 3, 2026 3.39 Mn
Jan 2, 2026 -13.81 Mn
Oct 3, 2025 4.15 Mn
Jul 4, 2025 -2.64 Mn
Apr 4, 2025 71,000.00
Jan 3, 2025 -2.76 Mn
Sep 27, 2024 384,000.00
Jun 28, 2024 -1.36 Mn
Mar 29, 2024 -1.72 Mn
Dec 29, 2023 -1.53 Mn
Sep 29, 2023 1.69 Mn
Jun 30, 2023 4.45 Mn
Mar 31, 2023 8.37 Mn
Dec 30, 2022 1.85 Mn
Sep 30, 2022 1.51 Mn
Jul 1, 2022 4.80 Mn
Apr 1, 2022 3.52 Mn
Dec 31, 2021 -13.75 Mn
Oct 1, 2021 18.94 Mn